Patents by Inventor Emily Long

Emily Long has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of Treating a Subject for Long-Haul COVID-19, and Compositions for Use in the Same
    Publication number: 20250099444
    Abstract: Methods of treating a subject for long-haul COVID are provided. Aspects of the methods include administering to the subject a tropane CCR5/CCL5 interaction inhibitor in combination with a statin to treat the subject for long-haul COVID. Also provided are compositions for use in practicing the methods.
    Type: Application
    Filed: January 23, 2023
    Publication date: March 27, 2025
    Inventors: Bruce K. Patterson, Edgar B. Francisco, Amruta Pise, Emily Long
  • Methods of assigning a COVID pathological type based on a cytokine/chemokine panel
    Patent number: 12228580
    Abstract: Methods of assigning a COVID pathological type for a subject suffering from COVID-19 are provided. Aspects of the methods include assigning a COVID pathological type for the subject based on a determined quantitative, multiplex cytokine/chemokine panel in a test sample from the subject. Also provided are methods of treating a subject (e.g., a long hauler subject) for chronic COVID-19. Aspects of such methods include administering to the long hauler subject a CCR5/CCL5 interaction inhibitor to treat the long hauler subject. Also provided are compositions for use in practicing the methods. The methods and compositions find use in a variety of applications, including patient stratification, treatment and therapy determination and therapy response assessment.
    Type: Grant
    Filed: June 16, 2022
    Date of Patent: February 18, 2025
    Assignee: IncellDx, Inc.
    Inventors: Bruce K. Patterson, Edgar B. Francisco, Amruta Pise, Emily Long
  • Methods of Assigning a COVID Pathological Type and Compositions for Practicing the Same, and Methods of Treating a Subject for Chronic COVID-19
    Publication number: 20240019447
    Abstract: Methods of assigning a COVID pathological type for a subject suffering from COVID-19 are provided. Aspects of the methods include assigning a COVID pathological type for the subject based on a determined quantitative, multiplex cytokine/chemokine panel in a test sample from the subject. Also provided are methods of treating a subject (e.g., a long hauler subject) for chronic COVID-19. Aspects of such methods include administering to the long hauler subject a CCR5/CCL5 interaction inhibitor to treat the long hauler subject. Also provided are compositions for use in practicing the methods. The methods and compositions find use in a variety of applications, including patient stratification, treatment and therapy determination and therapy response assessment.
    Type: Application
    Filed: August 1, 2023
    Publication date: January 18, 2024
    Inventors: Bruce K. Patterson, Edgar B. Francisco, Amruta Pise, Emily Long
  • Methods of Assigning a COVID Pathological Type and Compositions for Practicing the Same, and Methods of Treating a Subject for Chronic COVID-19
    Publication number: 20220317134
    Abstract: Methods of assigning a COVID pathological type for a subject suffering from COVID-19 are provided. Aspects of the methods include assigning a COVID pathological type for the subject based on a determined quantitative, multiplex cytokine/chemokine panel in a test sample from the subject. Also provided are methods of treating a subject (e.g., a long hauler subject) for chronic COVID-19. Aspects of such methods include administering to the long hauler subject a CCR5/CCL5 interaction inhibitor to treat the long hauler subject. Also provided are compositions for use in practicing the methods. The methods and compositions find use in a variety of applications, including patient stratification, treatment and therapy determination and therapy response assessment.
    Type: Application
    Filed: June 16, 2022
    Publication date: October 6, 2022
    Inventors: Bruce K. Patterson, Edgar B. Francisco, Amruta Pise, Emily Long
  • Methods of treating a long-hauler subject for chronic COVID-19 by administering a CCR5 or CCL5 antagonist
    Patent number: 11402391
    Abstract: Methods of assigning a COVID pathological type for a subject suffering from COVID-19 are provided. Aspects of the methods include assigning a COVID pathological type for the subject based on a determined quantitative, multiplex cytokine/chemokine panel in a test sample from the subject. Also provided are methods of treating a subject (e.g., a long hauler subject) for chronic COVID-19. Aspects of such methods include administering to the long hauler subject a CCR5/CCL5 interaction inhibitor to treat the long hauler subject. Also provided are compositions for use in practicing the methods. The methods and compositions find use in a variety of applications, including patient stratification, treatment and therapy determination and therapy response assessment.
    Type: Grant
    Filed: June 17, 2021
    Date of Patent: August 2, 2022
    Assignee: IncellDx, Inc.
    Inventors: Bruce K. Patterson, Edgar B. Francisco, Amruta Pise, Emily Long
  • Methods of Assigning a COVID Pathological Type and Compositions for Practicing the Same, and Methods of Treating a Subject for Chronic COVID-19
    Publication number: 20210373034
    Abstract: Methods of assigning a COVID pathological type for a subject suffering from COVID-19 are provided. Aspects of the methods include assigning a COVID pathological type for the subject based on a determined quantitative, multiplex cytokine/chemokine panel in a test sample from the subject. Also provided are methods of treating a subject (e.g., a long hauler subject) for chronic COVID-19. Aspects of such methods include administering to the long hauler subject a CCR5/CCL5 interaction inhibitor to treat the long hauler subject. Also provided are compositions for use in practicing the methods. The methods and compositions find use in a variety of applications, including patient stratification, treatment and therapy determination and therapy response assessment.
    Type: Application
    Filed: June 17, 2021
    Publication date: December 2, 2021
    Inventors: Bruce K. Patterson, Edgar B. Francisco, Amruta Pise, Emily Long